Novo Nordisk has generated a DKK 12bn (USD 1.8bn) profit in the third quarter of 2021, significantly more than for the same period last year, where the bottom line was DKK 10.3bn (USD 1.6bn), according to its report released on Wednesday morning.
For the first nine months of the year, net profit totals DKK 36.8bn (USD 5.7bn) compared to DKK 32.8bn (USD 5.1bn) at the same point last year. That is an increase of 12 percent, the report states.
Already a subscriber? Log in.
Read the whole article
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.Start a free company trial today
Your trial for MedWatch has now started
With your free trial you get:
Full access to all locked articles on MedWatch.
Daily newsletter and ongoing top-newsletters. You can unsubscribe and subscribe to our newsletters anytime.
When your trial period expires
You will not be transferred to a paid subscription.
You will continue to receive our newsletters after the trial period expires. You can unsubscribe at the bottom of each newsletter.